Since we did not identify any sequence abnormality within the TP53 gene in the CRISPR-edited lines by using Next generation sequencing and multiplex ligation-dependent probe amplification, these findings suggested a pathological convergence toward the activation of this specific transcription factor between ALS and reduced levels of SYT13. This evidence concerns the gene TP53 and amyotrophic lateral sclerosis.